On Invalid Date, Canopy Growth (NASDAQ: CGC) reported Q4 2023 earnings per share (EPS) of -$1.97, up 49.46% year over year. Total Canopy Growth earnings for the quarter were -$163.01 million. In the same quarter last year, Canopy Growth's earnings per share (EPS) was -$3.90.
As of Q2 2024, Canopy Growth's earnings has grown year over year. Canopy Growth's earnings in the past year totalled -$952.65 million.
What was CGC's revenue last quarter?
On Invalid Date, Canopy Growth (NASDAQ: CGC) reported Q4 2023 revenue of $59.03 million up 4.7% year over year. In the same quarter last year, Canopy Growth's revenue was $61.93 million.
What was CGC's revenue growth in the past year?
As of Q2 2024, Canopy Growth's revenue has grown -10.51% year over year. This is 20.65 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.14%. Canopy Growth's revenue in the past year totalled $246.67 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.